Clinical Trial Update: Growth Hormone for Poor Responders in in Vitro Fertilization (IVF) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating growth hormone for poor responders in in vitro fertilization has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Poor Ovarian Reserve

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Ottawa Fertility Centre | Conditions: Infertility, Poor Ovarian Reserve | Phase 2 | Status: COMPLETED